CCR6 and neoplasm: The studies showed that this chemokine stimulates the migration of immune cells, that possess CCR6, such as B cells, T cells (particularly Th17 cells and Treg cells), natural killer T (NKT) cells, neutrophils and immature dendritic cells (DC) to the tumor site, which suppress its development8,9.